Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network.

Anti-Bacterial Agents / therapeutic use Anti-Infective Agents Cross Infection / drug therapy Humans Intensive Care Units Prohibitins Surveys and Questionnaires
Antimicrobial resistance epidemiology Antimicrobial use Computerization of ICUs Healthcare-associated infection ICU-acquired infection surveillance

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 06 01 2021
revised: 07 05 2021
accepted: 10 05 2021
pubmed: 29 5 2021
medline: 1 9 2021
entrez: 28 5 2021
Statut: ppublish

Résumé

A survey was undertaken to evaluate the level of computerization in intensive care units (ICUs) within a French network dedicated to the surveillance of healthcare-associated infections, antimicrobial use (AMU) and antimicrobial resistance (AMR) in ICUs (REA-REZO). Ninety-eight ICUs responded, and patient records were computerized in 57%, antimicrobial prescriptions were computerized in 59% and AMR epidemiology was computerized in 72%. AMU and AMR feedback was provided to the ICU itself for 77% and 65% of ICUs, respectively, and feedback was provided to the national surveillance for 79% and 65% of ICUs, respectively. This study suggests that the level of computerization in ICUs requires further improvement.

Identifiants

DOI: 10.1016/j.jhin.2021.05.002 PMID: 34048849
pubmed: 34048849
pii: S0195-6701(21)00205-X
doi: 10.1016/j.jhin.2021.05.002
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0
PHB2 protein, human 0
Prohibitins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Informations de copyright

Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

A Lepape (A)

Hospices Civils de Lyon, Hôpital Henry Gabrielle, REA-REZO Surveillance Network, Infections and Antibiotic Resistance in ICU, Saint Genis Laval, Lyon, France; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Critical Care, Pierre-Bénite, Lyon, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie, INSERM, Lyon, France. Electronic address: alain.lepape@chu-lyon.fr.

A Machut (A)

Hospices Civils de Lyon, Hôpital Henry Gabrielle, REA-REZO Surveillance Network, Infections and Antibiotic Resistance in ICU, Saint Genis Laval, Lyon, France; CPIAS Auvergne-Rhône-Alpes, Hospices Civils de Lyon, Hôpital Henry Gabrielle, Saint Genis Laval, Lyon, France.

S Gerbier-Colomban (S)

Hospices Civils de Lyon, Centre Hospitalier Edouard Herriot, Service Hygiène, Epidémiologie et Prévention, Lyon, France.

E Kuczewski (E)

Hospices Civils de Lyon, Centre Hospitalier Edouard Herriot, Service Hygiène, Epidémiologie et Prévention, Lyon, France.

J-P Rasigade (JP)

Hospices Civils de Lyon, Hôpital de la Croix Rousse, Institut des Agents Infectieux, Lyon, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie, INSERM, Lyon, France.

J-F Timsit (JF)

AP-HP, Bichat Claude Bernard University Hospital, Medical and Infectious Diseases Intensive Care Unit, Paris, France; University Sorbonne Paris Nord, Paris, France.

P Vanhems (P)

Hospices Civils de Lyon, Centre Hospitalier Edouard Herriot, Service Hygiène, Epidémiologie et Prévention, Lyon, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie, INSERM, Lyon, France.

F Wallet (F)

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Critical Care, Pierre-Bénite, Lyon, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie, INSERM, Lyon, France.

A Savey (A)

Hospices Civils de Lyon, Hôpital Henry Gabrielle, REA-REZO Surveillance Network, Infections and Antibiotic Resistance in ICU, Saint Genis Laval, Lyon, France; CPIAS Auvergne-Rhône-Alpes, Hospices Civils de Lyon, Hôpital Henry Gabrielle, Saint Genis Laval, Lyon, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie, INSERM, Lyon, France.

A Friggeri (A)

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Critical Care, Pierre-Bénite, Lyon, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie, INSERM, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Automated surveillance in French ICUs: is it...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Automated surveillance in French ICUs: is it...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie iatrogène › Infection croisée › Automated surveillance in French ICUs: is it...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Automated surveillance in French ICUs: is it...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Unités hospitalières › Unités de soins intensifs › Automated surveillance in French ICUs: is it...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines mitochondriales › Prohibitines › Automated surveillance in French ICUs: is it...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Automated surveillance in French ICUs: is it...